Increased mononuclear cell activation and apoptosis early after human liver transplantation is associated with reduced frequency of acute rejection

Liver Transplantation

Volumn 10, Issue 3, 2004, Pages 397-403

  Jonsson, Julie R ^a   Gu, Wenyi ^a   Vanags, Daina M ^a   Bishop, G Alex ^b   McCaughan, Geoffrey W ^b   Fawcett, Jonathan ^a,c   Lynch, Stephen V ^a,c   Balderson, Glenda A ^c   Powell, Elizabeth E ^a,c   Clouston, Andrew D ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD40 LIGAND; CORTICOSTEROID; CYCLOSPORIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; METHYLPREDNISOLONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; APOPTOSIS; ARTICLE; CELL ISOLATION; CHIMERA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; FREQUENCY ANALYSIS; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPIENT; REPERFUSION; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; APOPTOSIS; CYTOKINES; FEMALE; GRAFT REJECTION; HUMANS; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MIDDLE AGED; TIME FACTORS;

EID: 12144290878     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20084     Document Type: Article

References (31)

1. Gugenheim J, Samuel D, Reynes M, Bismuth H. Liver transplantation across ABO blood group barriers. Lancet 1990;336: 519-523.
2. Hubscher SG, Buckels JA, Elias E, McMaster P, Neuberger J. Vanishing bile-duct syndrome following liver transplantation - is it reversible? Transplantation 1991;51:1004-1010.
3. Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, et al. Update of the International Banff Schema for Liver Allograft Rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology 2000;31:792-799.
4. Rasmussen A, Davies HF, Jamieson NV, Evans DB, Calne RY. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation 1995;59:919-921.
5. Devlin J, Doherty D, Thomson L, Wong T, Donaldson P, Portmann B, et al. Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology 1998;27(4): 926-933.
6. Mazariegos GV, Reyes J, Marino IR, Demetris AJ, Flynn B, Irish W, et al. Weaning of immunosuppression in liver transplant recipients. Transplantation 1997;63(2):243-249.
7. Kamada N. Animal models of hepatic allograft rejection. Semin Liver Dis 1992;12(1):1-15.
8. Calne RY. Immunological tolerance - the liver effect. Immunol Rev 2000;174:280-282.
9. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992;339:1579-1582.
10. Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, et al. Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance. Hepatology 1993;17(6): 1127-1152.
11. Starzl TE, Zinkernagel RM. Antigen localization and migration in immunity and tolerance. N Engl J Med 1998;339(26):1905-1913.
12. Sharland A, Yan Y, Wang C, Bowen DG, Sun J, Sheil AG, et al. Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance. Transplantation 1999;68(11):1736-1745.
13. Hansen B, Janssen E, Machleidt T, Kronke M, Zavazava N. Purified truncated recombinant HLA-B7 molecules abrogate cell function in alloreactive cytotoxic T lymphocytes by apoptosis induction. Transplantation 1998;66(12):1818-1822.
14. Lechler R, Ng WF, Steinman RM. Dendritic cells in transplantation - friend or foe? Immunity 2001;14(4):357-368.
15. Qian S, Lu L, Fu F, Li Y, Li W, Starzl TE, et al. Apoptosis within spontaneously accepted mouse liver allografts: Evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol 1997;158(10):4654-4661.
16. Clouston AD, Jonsson JR, Balderson GA, Fawcett J, Lynch SV, Kelso A, et al. Lymphocyte apoptosis and cell replacement in human liver allografts. Transplantation 2002;73(11):1828-1834.
17. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162(1):156-159.
18. Yin JL, Shackel NA, Zekry A, McGuinness PH, Richards C, Van der Putten K, et al. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. Immunol Cell Biol 2001;79 (3):213-221.
19. Knoop C, Andrien M, Defleur V, Antonine M, de Francquen P, Goldman M, et al. Detection of blood chimerism after lung and heart-lung transplantation. The superiority of nested as compared with standard polymerase chain reaction amplification. Transplantation 1994;58(12):1335-1338.
20. Jonsson JR, Hogan PG, Thomas R, Steadman C, Clouston AD, Balderson GA, et al. Peripheral blood chimerism following human liver transplantation. Hepatology 1997;25(5):1233-1236.
21. Staley K, Blaschke A, Chun J. Apoptotic DNA fragmentation is detected by a semiquantitative ligation-mediated PCR of blunt DNA ends. Cell Death and Differentiation 1997;4(1):66-75.
22. Vanags DM, Porn-Ares MI, Coppola S, Burgess DH, Orrenius S. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J Biol Chem 1996;271(49):31075-31085.
23. Bishop GA, Sun JH, DeCruz DJ, Rokahr KL, Sedgwick JD, Sheil AGR, et al. Tolerance to rat liver allografts .3. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues. J Immunol 1996;156 (12):4925-4931.
24. Sharland A, Shastry S, Wang C, Rokahr K, Sun J, Sheil AG, et al. Kinetics of intragraft cytokine expression, cellular infiltration, and cell death in rejection of renal allografts compared with acceptance of liver allografts in a rat model: Early activation and apoptosis is associated with liver graft acceptance. Transplantation 1998;65(10):1370-1377.
25. Bishop GA, Wang C, Sharland AF, McCaughan G. Spontaneous acceptance of liver transplants in rodents: Evidence that liver leukocytes induce recipient T-cell death by neglect. Immunol Cell Biol 2002;80:93-100.
26. Renno T, Hahne M, MacDonald HR. Proliferation is a prerequisite for bacterial superantigen-induced T cell apoptosis in vivo. J Exp Med 1995;181(6):2283-2287.
27. Garside P, Mowat AM. Oral tolerance. Semin Immunol 2001; 13(3):177-185.
28. Sun J, Sheil AG, Wang C, Wang L, Rokahr K, Sharland A, et al. Tolerance to rat liver allografts: IV. Acceptance depends on the quantity of donor tissue and on donor leukocytes. Transplantation 1996;62(12):1725-1730.
29. Rokahr KL, Sharland AF, Sun J, Wang C, Sheil AG, Yan Y, et al. Paradoxical early immune activation during acceptance of liver allografts compared with rejection of skin grafts in a rat model of transplantation. Immunology 1998;95(2):257-263.
30. Tu Y, Arima T, Flye MW. Rejection of spontaneously accepted rat liver allografts with recipient interleukin-2 treatment or donor irradiation. Transplantation 1997;63(2):177-181.
31. Qian S, Lu L, Fu F, Li W, Pan F, Steptoe RJ, et al. Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. Transplantation 1998;65(12):1590-1598.